2010
DOI: 10.1007/s12272-010-0719-y
|View full text |Cite
|
Sign up to set email alerts
|

The phosphoinositide-3-kinase/Akt pathway mediates the transient increase in Nanog expression during differentiation of F9 cells

Abstract: Nanog is a key determinant that maintains self-renewal and pluripotency of embryonic stem cells and represses their differentiation to endoderm. In this study, we examined the regulation of Nanog expression by phosphoinositide-3-kinase (PI3K)/Akt pathway during retinoic acid (RA)-induced differentiation of F9 embryonic carcinoma cells. Nanog protein expression was transiently upregulated up to 6 h after RA treatment and then declined. In agreement, a murine Nanog promoter reporter assay revealed that promoter … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
26
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(29 citation statements)
references
References 29 publications
(43 reference statements)
2
26
1
Order By: Relevance
“…Although RA was previously described as an inducer of differentiation, its presence promotes AKT-dependent phosphorylation of the chromatin remodeler SATB1, which binds to SOX2 thereby preventing it from associating with Oct4 to maintain pluripotency. In addition, and contrary to what was described earlier [186], active AKT signaling in P19 cells induces a transient increase in Nanog expression [187], which seems counterintuitive because AKT inhibits pluripotency markers. However, it is more complex than this as Oct4 in ECCs can bind to the human AKT1 promoter, and this is dependent on its phosphorylation state controlled by AKT itself [188].…”
Section: Pluripotency Factors and Signaling Crosstalkcontrasting
confidence: 81%
“…Although RA was previously described as an inducer of differentiation, its presence promotes AKT-dependent phosphorylation of the chromatin remodeler SATB1, which binds to SOX2 thereby preventing it from associating with Oct4 to maintain pluripotency. In addition, and contrary to what was described earlier [186], active AKT signaling in P19 cells induces a transient increase in Nanog expression [187], which seems counterintuitive because AKT inhibits pluripotency markers. However, it is more complex than this as Oct4 in ECCs can bind to the human AKT1 promoter, and this is dependent on its phosphorylation state controlled by AKT itself [188].…”
Section: Pluripotency Factors and Signaling Crosstalkcontrasting
confidence: 81%
“…The expression of Nanog, the second most important pluripotent gene, can be positively regulated by RA, as has been shown in some recent studies [77, 86]. In this case, Nanog expression is probably induced through the induction of insulin-like growth factor (IGF) expression by RA or other retinoids [86]. IGF is a strong inductor of the PI3-K pathway, whose activity leads to the increasing expression of Nanog in ES cells [87, 88].…”
Section: Alkaline Phosphatase and Stem Cellsmentioning
confidence: 72%
“…However, the expression of Oct-4 is directly inhibited by RA [85]. The expression of Nanog, the second most important pluripotent gene, can be positively regulated by RA, as has been shown in some recent studies [77, 86]. In this case, Nanog expression is probably induced through the induction of insulin-like growth factor (IGF) expression by RA or other retinoids [86].…”
Section: Alkaline Phosphatase and Stem Cellsmentioning
confidence: 99%
“…Whether ATRA increases or decreases PI3K activity appears to vary with cell type. For example, in differentiating F9 and glial cells, ATRA increases PI3K activity (33,34). With respect to cancer cells, ATRA has been shown to induce PI3K activity in MCF-7 breast cancer cells (15).…”
Section: Discussionmentioning
confidence: 99%